As the title implies, this final rule clarifies and amends the discount safe harbor at 42 C.F.R. § 1001.925(h) under the federal Anti-kickback statute (AKS) such that rebates paid from drug manufacturers to Medicare Part D prescription drug plan sponsors or their pharmacy benefit managers (PBMs) are not protected from liability under the discount safe harbor. The rule also adds a new safe harbor for point-of-sale reductions in price that are passed on directly to a buyer (a defined term under the rule) and an additional safe harbor for “legitimate” service fees paid to PBMs by drug manufacturers.
OIG Finalizes Rebate Rules: Removal of Safe Harbor Protections for Rebates and Creation of New Safe Harbors for Other Discounts and Service Fees
More Issues
Wade’s Health Law Highlights for September 29, 2026
The Department of Justice revised the Justice Manual to limit the use of sub-regulatory guidance in False Claims Act enforcement and to direct attorneys…
Wade’s Health Law Highlights for September 22, 2026
Nearly $12 billion in Medicaid supplemental funding to Texas hospitals will be restored, ending a year-long impasse between Texas and the federal government. Gov.…
Wade’s Health Law Highlights for September 15, 2026
The D.C. Circuit held that a manufacturer’s offer of up to $70,000 in fertility support to patients prescribed its gene therapy would violate the…
